ABSTRACT
Cannabis may be an effective alternative or adjunctive treatment for peripheral neuropathy, an often debilitating condition for which standard treatments often provide little relief. Most studies show moderately improved pain from inhaled cannabis use, but adverse effects such as impaired cognition and respiratory problems are common, especially at high doses. Data on the long-term safety of cannabis treatments are limited. Until riskbenefit profiles are better characterized, doctors in states where cannabis therapy is legal should recommend it for peripheral neuropathy only after careful consideration.
- Copyright © 2018 The Cleveland Clinic Foundation. All Rights Reserved.
- Vania Modesto-Lowe, MD, MPH⇑
- Connecticut Valley Hospital, Middletown, CT
- Quinnipiac University, Hamden, CT
- University of Connecticut School of Medicine, Farmington
- ADDRESS:
Vania Modesto-Lowe, MD, MPH, Connecticut Valley Hospital, PO Box 351, Silver Street, Middletown, CT 06457; vania.modesto-lowe{at}ct.gov
ABSTRACT
Cannabis may be an effective alternative or adjunctive treatment for peripheral neuropathy, an often debilitating condition for which standard treatments often provide little relief. Most studies show moderately improved pain from inhaled cannabis use, but adverse effects such as impaired cognition and respiratory problems are common, especially at high doses. Data on the long-term safety of cannabis treatments are limited. Until riskbenefit profiles are better characterized, doctors in states where cannabis therapy is legal should recommend it for peripheral neuropathy only after careful consideration.
- Copyright © 2018 The Cleveland Clinic Foundation. All Rights Reserved.
Jump to section
- Article
- ABSTRACT
- PERIPHERAL NEUROPATHY IS COMMON AND COMPLEX
- STANDARD TREATMENTS INADEQUATE
- CANNABIS: A MIX OF COMPOUNDS
- THE ENDOCANNABINOID SYSTEM
- STUDIES OF CANNABIS FOR NEUROPATHIC PAIN
- CBD MAY PROTECT AGAINST ADVERSE EFFECTS
- META-ANALYSES CONFIRM EFFECT
- RISKS OF CANNABIS USE
- SHOULD WE RECOMMEND CANNABIS?
- ACKNOWLEDGMENTS
- REFERENCES
- Info & Metrics